Dronedarone in patients with congestive heart failure: insights from ATHENA

Stefan H Hohnloser, Harry J G M Crijns, Martin van Eickels, Christophe Gaudin, Richard L Page, Christian Torp-Pedersen, Stuart J Connolly, ATHENA Investigators

    59 Citationer (Scopus)

    Abstract

    Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF.
    OriginalsprogEngelsk
    TidsskriftEuropean Heart Journal
    Vol/bind31
    Udgave nummer14
    Sider (fra-til)1717-21
    Antal sider5
    ISSN0195-668X
    DOI
    StatusUdgivet - 1 jul. 2010

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Dronedarone in patients with congestive heart failure: insights from ATHENA'. Sammen danner de et unikt fingeraftryk.

    Citationsformater